Cite
HARVARD Citation
Huang, H. et al. (2022). A pilot randomized controlled trial of de novo belatacept‐based immunosuppression following anti‐thymocyte globulin induction in lung transplantation. American journal of transplantation. 22 (7), pp. 1884-1892. [Online].